15.600
+0,00%
2026-10-09
Fundamental Analysis
37 / 100BRubric: Manufacturing
| Quarterly results | Relative Valuation | |||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Criterion | Latest Q EPS growth (YoY) | Avg EPS growth, last 3 (YoY) | Quarters with EPS growth | Revenue growth (YoY) | Gross margin change (pp, YoY) | Net margin change (pp, YoY) | Return on Equity (TTM) | Financial health (Debt/Equity) | Valuation (P/E vs 5-yr median) | Revenue (bn) | Rev YoY | NPAT (bn) | NPAT YoY | P/E | 5-Year Median P/E | P/E vs. 5-Year Median |
| Value | +5.7% | +7.6% | 3 / 3 | +8.0% | +2.35 pp | -0.17 pp | +13.2% | 0.00 | 6.07 | 82,1 | +8,0% | 3,4 | +3,8% | 6.07 | 4.82 | +26,0% |
| Pts | 0 | 0 | 12 | 0 | 8 | 4 | 0 | 12 | 4 | |||||||
Valuation annotation:Price: 15.600 (close price on 2026-10-09)EPS (TTM): 2.568
Financial charts
1.Revenue & growth
VND bn82,1Q2/26
1.Revenue & growth
VND bn82,1Q2/26
2.Profit & growth
VND bn3,41Q2/26
3.Profit mix (Penman)
VND bn17,5Q2/26
4.Margins & cost structure
%11.2%Q2/26
5.Returns & cash cycle
% · days18.9%Q2/26
6.Earnings quality & cash
VND bn11,7Q2/26
7.Asset structure
VND bn132Q2/26
8.Funding & debt health
VND bn · times132Q2/26
9.Revenue backlog
VND bn0,00Q2/26
10.Valuation
times · %6,1×Q2/26
11.EPS growth & dilution warning (CANSLIM)
VND per share; growth in %677Q2/26
Adjusted EPS growth, latest quarter
5.7%
Average adjusted EPS growth, 3 quarters
7.6%
Quarters at 25%+ growth
0/3
Share dilution rate, 1 year
0.0%
Source: vnstockData through Q2/26